Jijun Dong
Chief Scientific Officer Salubris Therapeutics
Seminars
Tuesday 15th September 2026
Improving Translational Confidence Through Human-Relevant Models & AI-Enabled Insights to Accelerate Next-Generation MASH Therapies
12:30 pm
- Evaluating which translational tools are most effectively predicting clinical success to strengthen target validation and reduce late-stage development risk
- Identifying gaps between preclinical efficacy signals and clinical outcomes to improve development decision-making and accelerate candidate progression
- Exploring how AI-enabled discovery platforms, advanced models and translational biomarkers can improve confidence in next-generation therapeutic development
